PAR 2.38% 20.5¢ paradigm biopharmaceuticals limited..

Another small point of note, is that in terms of the Resolution...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,783 Posts.
    lightbulb Created with Sketch. 1969
    Another small point of note, is that in terms of the Resolution to increase the remuneration pool for the BOD....this is for any potential expansion of the board, rather than to bump up the fees of the incumbent directors. The idea which the Chairman presented, is that this is pre-emptive due to the fact that they are targeting a break into the US marketplace, and so we may want to bring in a US director or two in the not-too-distant. I find this to be a sound strategy, and hints - along with other revelations today about the boards process to decide on a preferred pharma partner - that these guys are aiming to see the journey through, rather than position the listco for an all out takeover. Just the vibe I got.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
20.5¢
Change
-0.005(2.38%)
Mkt cap ! $71.73M
Open High Low Value Volume
20.0¢ 21.0¢ 20.0¢ $152.8K 744.7K

Buyers (Bids)

No. Vol. Price($)
3 78174 20.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 84426 5
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.